These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1651361)

  • 1. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.
    Gerna G; Zipeto D; Parea M; Revello MG; Silini E; Percivalle E; Zavattoni M; Grossi P; Milanesi G
    J Infect Dis; 1991 Sep; 164(3):488-98. PubMed ID: 1651361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
    Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
    J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human cytomegalovirus myocardial involvement by polymerase chain reaction during systemic infection and correlation with pp65 antigenemia and DNAemia in infected heart recipients.
    Ghisetti V; Barbui A; Rocci MP; Donegani E; Bobbio M; Pucci A; Papandrea C; Pansini S; Zattera G; Mollo F; Di Summa M; Marchiaro G
    Transplantation; 1996 Apr; 61(7):1072-5. PubMed ID: 8623188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
    Baldanti F; Revello MG; Percivalle E; Gerna G
    J Clin Virol; 1998 Jul; 11(1):51-60. PubMed ID: 9784143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
    Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
    Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
    Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
    Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F
    Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection.
    Freymuth F; Gennetay E; Petitjean J; Eugene G; Hurault de Ligny B; Ryckelynck JP; Legoff C; Hazera P; Bazin C
    J Clin Microbiol; 1994 Jun; 32(6):1614-8. PubMed ID: 8077418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns.
    Revello MG; Zavattoni M; Baldanti F; Sarasini A; Paolucci S; Gerna G
    J Clin Virol; 1999 Sep; 14(1):57-66. PubMed ID: 10548131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
    Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
    J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes.
    Kühn JE; Wendland T; Schäfer P; Möhring K; Wieland U; Elgas M; Eggers HJ
    J Med Virol; 1994 Dec; 44(4):398-405. PubMed ID: 7897371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative quantification of human cytomegalovirus DNA in blood of immunocompromised patients by PCR and Murex Hybrid Capture System.
    Baldanti F; Zavattoni M; Sarasini A; Gatti M; Chezzi L; Gerna G
    Clin Diagn Virol; 1997 Aug; 8(2):159-65. PubMed ID: 9316737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients.
    Gerna G; Sarasini A; Lilleri D; Percivalle E; Torsellini M; Baldanti F; Revello MG
    J Infect Dis; 2003 Dec; 188(11):1639-47. PubMed ID: 14639533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
    Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
    Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.